Get started
Author

Ankita Anand

Observed institution: New Delhi Tuberculosis Center
ORCID: 0009-0000-8697-8752
Observed ORCID: 0009-0000-8697-8752
OpenAlex ID: A5123668399
Analytical performance of a multi-target open real-time PCR assay for simultaneous detection of tuberculosis, non-tuberculous mycobacteria, and drug resistance in a high-burden setting
2026 · Zeeshan Sidiq, Ankita Anand, et al. · Microbiology Spectrum · 2
PDF
Diagnostic accuracy, operational feasibility, and cost considerations of Truenat MTB Plus and Xpert MTB/RIF Ultra for pulmonary tuberculosis
2026 · Zeeshan Sidiq, Ankita Anand, et al. · PLoS ONE · 1
PDF
Community empowerment in tuberculosis elimination
2026 · Vijay Kumar Arora, Sanjay Rajpal, et al. · Indian Journal of Tuberculosis · 1
Open-Platform Real-Time PCR for Tuberculosis in India: From Diagnostic Validation to Strategic Integration
2026 · Zeeshan Sidiq, Ankita Anand, et al. · Indian Journal of Tuberculosis
Prevalence of fluoroquinolone resistance in treatment naive tuberculosis patients
2026 · Zeeshan Sidiq, Ankita Anand, et al. · Indian Journal of Tuberculosis
NTEP: A Historical Overview and Vision for the Future of Tuberculosis Elimination
2025 · Sanjay Rajpal, Kamal Kishore Chopra, et al. · Journal of the Indian Medical Association
PDF
Works count: 6
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type